Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.
Sus Clinicals has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Sus Clinicals is headquartered in Cincinnati, United States.
Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.
Sus Clinicals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sus Clinicals — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/sus-clinicals. Accessed November 13, 2026.
VCBacked. (2024). Sus Clinicals — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/sus-clinicals
{{cite web |title=Sus Clinicals — Funding & Investors |url=https://www.vcbacked.co/company/sus-clinicals |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sus Clinicals? Request a listing update